Replies to post #212598 on Amarin Corp Plc (AMRN)

[massulo52]

We got a B+

[Mellowmood77]

B+ is for clinical significance not cost effectiveness.

The cost effectiveness was rated at $18k/QALY. It should really be 13k to 16k/qaly.

I wrote an entire post on the cost effectiveness a couple days ago if you want to know more on how this is calculated.